Item 9 Labs Corp.
INLB · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $5,448 | $10,108 | $12,395 | $38,087 |
| - Cash | $183 | $101 | $22 | $86 |
| + Debt | $34,295 | $33,875 | $32,589 | $27,845 |
| Enterprise Value | $39,560 | $43,882 | $44,962 | $65,846 |
| Revenue | $5,022 | $5,663 | $5,004 | $4,001 |
| % Growth | -11.3% | 13.2% | 25.1% | – |
| Gross Profit | $2,819 | $3,718 | $2,622 | $646 |
| % Margin | 56.1% | 65.7% | 52.4% | 16.1% |
| EBITDA | -$2,533 | -$853 | -$958 | -$15,485 |
| % Margin | -50.4% | -15.1% | -19.2% | -387% |
| Net Income | -$5,911 | -$3,407 | -$3,248 | -$18,449 |
| % Margin | -117.7% | -60.2% | -64.9% | -461.1% |
| EPS Diluted | -0.058 | -0.034 | -0.033 | -0.19 |
| % Growth | -72.1% | -2.7% | 82.7% | – |
| Operating Cash Flow | $150 | $303 | -$1,335 | -$238 |
| Capital Expenditures | -$63 | $1 | -$7 | -$1,409 |
| Free Cash Flow | $87 | $304 | -$1,341 | -$1,647 |